Restructuring

Precedent-setting perspective on current bankruptcy and restructuring situations, plus weekly takes on companies that will likely be in need of advisory assistance.

Restructuring Intelligence

News From The Deal

Pills Emerge Amid Tariff Uncertainty, Activism

As the markets face tariff-related volatility, some companies, especially biotechnology and pharmaceuticals companies, are setting up or extending shareholder rights plans, known as poison pills, to discourage unsolicited bidders and activist accumulations.